QurAlis Announces Development Candidate for ALS Targeting STATHMIN-2 ...Middle East

PR Newswire - News
QurAlis Announces Development Candidate for ALS Targeting STATHMIN-2
CAMBRIDGE, Mass., Sept. 14, 2021 /PRNewswire/ -- QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases with genetically validated targets, today announced the nomination of QRL-201 as...

Hence then, the article about quralis announces development candidate for als targeting stathmin 2 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( QurAlis Announces Development Candidate for ALS Targeting STATHMIN-2 )

Apple Storegoogle play

Last updated :

Also on site :